Chemed (CHE) Long-Term Debt Repayments (2009 - 2026)

Chemed has reported Long-Term Debt Repayments for 12 years, with the latest figure at $44.3 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Debt Repayments changed N/A year-over-year to $44.3 million; the trailing twelve-month figure through Mar 2026 stood at $164.0 million (changed N/A YoY), and the FY2022 full-year result was $306.8 million, up 1112.65% from the prior year.
• Long-Term Debt Repayments for Q1 2026 stood at $44.3 million, down from $76.2 million in the prior quarter.
• The five-year high for Long-Term Debt Repayments was $176.8 million in Q2 2022, with the low at $7.4 million in Q4 2022.
• Average Long-Term Debt Repayments over 3 years is $71.2 million, with a median of $60.3 million recorded in 2023.
• Year-over-year, Long-Term Debt Repayments sank 68.91% in 2022 and retreated 11.85% in 2023.
• Tracing CHE's Long-Term Debt Repayments over 3 years: stood at $7.4 million in 2022, then soared by 930.41% to $76.2 million in 2023, then plunged by 41.93% to $44.3 million in 2026.
• The last three Long-Term Debt Repayments figures came in at $44.3 million (Q1 2026), $76.2 million (Q1 2023), and $7.4 million (Q4 2022), per Business Quant data.

Peer Comparison